• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶体亚型的功能差异。

Functional Differences between Proteasome Subtypes.

机构信息

Ludwig Institute for Cancer Research, 1200 Brussels, Belgium.

De Duve Institute, Université Catholique de Louvain, 1200 Brussels, Belgium.

出版信息

Cells. 2022 Jan 26;11(3):421. doi: 10.3390/cells11030421.

DOI:10.3390/cells11030421
PMID:35159231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8834425/
Abstract

Four proteasome subtypes are commonly present in mammalian tissues: standard proteasomes, which contain the standard catalytic subunits β1, β2 and β5; immunoproteasomes containing the immuno-subunits β1i, β2i and β5i; and two intermediate proteasomes, containing a mix of standard and immuno-subunits. Recent studies revealed the expression of two tissue-specific proteasome subtypes in cortical thymic epithelial cells and in testes: thymoproteasomes and spermatoproteasomes. In this review, we describe the mechanisms that enable the ATP- and ubiquitin-dependent as well as the ATP- and ubiquitin-independent degradation of proteins by the proteasome. We focus on understanding the role of the different proteasome subtypes in maintaining protein homeostasis in normal physiological conditions through the ATP- and ubiquitin-dependent degradation of proteins. Additionally, we discuss the role of each proteasome subtype in the ATP- and ubiquitin-independent degradation of disordered proteins. We also discuss the role of the proteasome in the generation of peptides presented by MHC class I molecules and the implication of having different proteasome subtypes for the peptide repertoire presented at the cell surface. Finally, we discuss the role of the immunoproteasome in immune cells and its modulation as a potential therapy for autoimmune diseases.

摘要

四种蛋白酶体亚型通常存在于哺乳动物组织中

标准蛋白酶体,包含标准催化亚基β1、β2 和β5;免疫蛋白酶体,包含免疫亚基β1i、β2i 和β5i;以及两种中间蛋白酶体,包含标准和免疫亚基的混合物。最近的研究揭示了皮质胸腺上皮细胞和睾丸中两种组织特异性蛋白酶体亚型的表达:胸腺蛋白酶体和精子蛋白酶体。在这篇综述中,我们描述了蛋白酶体通过 ATP 和泛素依赖性以及 ATP 和泛素非依赖性降解蛋白质的机制。我们专注于理解不同蛋白酶体亚型在通过 ATP 和泛素依赖性降解蛋白质来维持正常生理条件下的蛋白质平衡中的作用。此外,我们讨论了每种蛋白酶体亚型在无规蛋白质的 ATP 和泛素非依赖性降解中的作用。我们还讨论了蛋白酶体在 MHC Ⅰ类分子呈递肽中的作用以及存在不同蛋白酶体亚型对细胞表面呈递肽谱的影响。最后,我们讨论了免疫蛋白酶体在免疫细胞中的作用及其作为自身免疫性疾病潜在治疗方法的调节作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/8834425/accd4d672ea4/cells-11-00421-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/8834425/c721968e7808/cells-11-00421-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/8834425/08cbcc0091f6/cells-11-00421-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/8834425/ef6eb393b963/cells-11-00421-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/8834425/20abe2b901d2/cells-11-00421-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/8834425/accd4d672ea4/cells-11-00421-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/8834425/c721968e7808/cells-11-00421-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/8834425/08cbcc0091f6/cells-11-00421-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/8834425/ef6eb393b963/cells-11-00421-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/8834425/20abe2b901d2/cells-11-00421-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/8834425/accd4d672ea4/cells-11-00421-g005.jpg

相似文献

1
Functional Differences between Proteasome Subtypes.蛋白酶体亚型的功能差异。
Cells. 2022 Jan 26;11(3):421. doi: 10.3390/cells11030421.
2
The Molecular Mechanisms Governing the Assembly of the Immuno- and Thymoproteasomes in the Presence of Constitutive Proteasomes.在组成性蛋白酶体存在的情况下,免疫蛋白酶体和胸腺蛋白酶体组装的分子机制。
Cells. 2022 May 7;11(9):1580. doi: 10.3390/cells11091580.
3
Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules.两种丰富的蛋白酶体亚型,它们独特地处理由 HLA Ⅰ类分子呈递的某些抗原。
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18599-604. doi: 10.1073/pnas.1009778107. Epub 2010 Oct 11.
4
Efficiency of the four proteasome subtypes to degrade ubiquitinated or oxidized proteins.四种蛋白酶体亚型降解泛素化或氧化蛋白质的效率。
Sci Rep. 2020 Sep 25;10(1):15765. doi: 10.1038/s41598-020-71550-5.
5
The proteasome system in infection: impact of β5 and LMP7 on composition, maturation and quantity of active proteasome complexes.蛋白酶体系统在感染中的作用:β5 和 LMP7 对活性蛋白酶体复合物的组成、成熟和数量的影响。
PLoS One. 2012;7(6):e39827. doi: 10.1371/journal.pone.0039827. Epub 2012 Jun 29.
6
On the Role of the Immunoproteasome in Protein Homeostasis.免疫蛋白酶体在蛋白质稳态中的作用
Cells. 2021 Nov 18;10(11):3216. doi: 10.3390/cells10113216.
7
Analysis of the processing of seven human tumor antigens by intermediate proteasomes.中间蛋白酶体对七种人肿瘤抗原的加工分析。
J Immunol. 2012 Oct 1;189(7):3538-47. doi: 10.4049/jimmunol.1103213. Epub 2012 Aug 27.
8
Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complex.蛋白酶体亚型及调节因子在主要组织相容性复合体I类分子提呈的抗原肽加工过程中的作用
Biomolecules. 2014 Nov 18;4(4):994-1025. doi: 10.3390/biom4040994.
9
The 20S immunoproteasome and constitutive proteasome bind with the same affinity to PA28αβ and equally degrade FAT10.20S 免疫蛋白酶体和组成型蛋白酶体与 PA28αβ 的结合亲和力相同,并同样降解 FAT10。
Mol Immunol. 2019 Sep;113:22-30. doi: 10.1016/j.molimm.2017.11.030. Epub 2017 Dec 6.
10
The role of the proteasome in the generation of MHC class I ligands and immune responses.蛋白酶体在 MHC I 类配体产生和免疫反应中的作用。
Cell Mol Life Sci. 2011 May;68(9):1491-502. doi: 10.1007/s00018-011-0657-y. Epub 2011 Mar 9.

引用本文的文献

1
Inhibition of Proteasome LMP2 Activity Suppresses Expression in Mouse Colon Adenocarcinoma Tissue and Restrains Tumor Growth.蛋白酶体LMP2活性的抑制可抑制小鼠结肠腺癌组织中的表达并抑制肿瘤生长。
Oncol Res. 2025 Aug 28;33(9):2573-2595. doi: 10.32604/or.2025.066611. eCollection 2025.
2
hu.MAP3.0: atlas of human protein complexes by integration of >25,000 proteomic experiments.hu.MAP3.0:通过整合25000多项蛋白质组学实验构建的人类蛋白质复合物图谱
Mol Syst Biol. 2025 May 27. doi: 10.1038/s44320-025-00121-5.
3
Ubiquitin-proteasome system in the different stages of dominantly inherited Alzheimer's disease.

本文引用的文献

1
Navigating Critical Challenges Associated with Immunopeptidomics-Based Detection of Proteasomal Spliced Peptide Candidates.应对基于免疫肽组学检测蛋白酶体剪接肽候选物所面临的关键挑战。
Cancer Immunol Res. 2022 Mar 1;10(3):275-284. doi: 10.1158/2326-6066.CIR-21-0727.
2
Concept and application of circulating proteasomes.循环蛋白酶体的概念与应用。
Exp Mol Med. 2021 Oct;53(10):1539-1546. doi: 10.1038/s12276-021-00692-x. Epub 2021 Oct 27.
3
M3258 Is a Selective Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) Delivering Efficacy in Multiple Myeloma Models.
常染色体显性遗传阿尔茨海默病不同阶段的泛素-蛋白酶体系统
Alzheimers Dement. 2025 May;21(5):e70243. doi: 10.1002/alz.70243.
4
Peptide-MHC I regulatory mechanisms and intervention strategies in anti-tumor T cell immunity.肽-MHC I在抗肿瘤T细胞免疫中的调节机制及干预策略
Acta Pharmacol Sin. 2025 May 16. doi: 10.1038/s41401-025-01574-y.
5
The roles of the ubiquitin-proteasome system in renal disease.泛素 - 蛋白酶体系统在肾脏疾病中的作用。
Int J Med Sci. 2025 Mar 10;22(8):1791-1810. doi: 10.7150/ijms.107284. eCollection 2025.
6
The Role of the Ubiquitin System in Eye Diseases.泛素系统在眼部疾病中的作用。
Life (Basel). 2025 Mar 20;15(3):504. doi: 10.3390/life15030504.
7
Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease.不依赖泛素的蛋白酶体降解机制及其在年龄相关性神经退行性疾病中的作用。
Front Cell Dev Biol. 2025 Feb 7;12:1531797. doi: 10.3389/fcell.2024.1531797. eCollection 2024.
8
Tracking proteasome degradation: A cross-organ analysis via intact degradomics mass spectrometry.追踪蛋白酶体降解:通过完整降解组学质谱法进行的跨器官分析。
Proc Natl Acad Sci U S A. 2025 Feb 25;122(8):e2419607122. doi: 10.1073/pnas.2419607122. Epub 2025 Feb 18.
9
An AI-assisted morphoproteomic approach is a supportive tool in esophagitis-related precision medicine.人工智能辅助的形态蛋白质组学方法是食管炎相关精准医学中的一种辅助工具。
EMBO Mol Med. 2025 Mar;17(3):441-468. doi: 10.1038/s44321-025-00194-7. Epub 2025 Feb 3.
10
Molecular insights into the unique properties of the blood-circulating proteasome.对血液循环蛋白酶体独特性质的分子见解。
J Extracell Biol. 2025 Jan 27;4(1):e70034. doi: 10.1002/jex2.70034. eCollection 2025 Jan.
M3258 是一种选择性免疫蛋白酶体亚单位 LMP7(β5i)抑制剂,在多发性骨髓瘤模型中具有疗效。
Mol Cancer Ther. 2021 Aug;20(8):1378-1387. doi: 10.1158/1535-7163.MCT-21-0005. Epub 2021 May 27.
4
Activity of immunoproteasome inhibitor ONX-0914 in acute lymphoblastic leukemia expressing MLL-AF4 fusion protein.免疫蛋白酶体抑制剂 ONX-0914 在表达 MLL-AF4 融合蛋白的急性淋巴细胞白血病中的活性。
Sci Rep. 2021 May 25;11(1):10883. doi: 10.1038/s41598-021-90451-9.
5
An Integrated Genomic, Proteomic, and Immunopeptidomic Approach to Discover Treatment-Induced Neoantigens.一种综合基因组、蛋白质组和免疫肽组学方法来发现治疗诱导的新抗原。
Front Immunol. 2021 Apr 15;12:662443. doi: 10.3389/fimmu.2021.662443. eCollection 2021.
6
Pro- and Antitumorigenic Capacity of Immunoproteasomes in Shaping the Tumor Microenvironment.免疫蛋白酶体在塑造肿瘤微环境中的促肿瘤和抗肿瘤能力。
Cancer Immunol Res. 2021 Jun;9(6):682-692. doi: 10.1158/2326-6066.CIR-20-0492. Epub 2021 Mar 11.
7
Cryo-EM of mammalian PA28αβ-iCP immunoproteasome reveals a distinct mechanism of proteasome activation by PA28αβ.哺乳动物 PA28αβ-iCP 免疫蛋白酶体的冷冻电镜显示了 PA28αβ 激活蛋白酶体的独特机制。
Nat Commun. 2021 Feb 2;12(1):739. doi: 10.1038/s41467-021-21028-3.
8
Conformational maps of human 20S proteasomes reveal PA28- and immuno-dependent inter-ring crosstalks.人类 20S 蛋白酶体的构象图谱揭示了 PA28-和免疫依赖性的环间串扰。
Nat Commun. 2020 Dec 1;11(1):6140. doi: 10.1038/s41467-020-19934-z.
9
Proteasome subunit α4s is essential for formation of spermatoproteasomes and histone degradation during meiotic DNA repair in spermatocytes.蛋白酶体亚基 α4s 对于精母细胞减数分裂 DNA 修复过程中形成精子蛋白酶体和组蛋白降解是必需的。
J Biol Chem. 2021 Jan-Jun;296:100130. doi: 10.1074/jbc.RA120.016485. Epub 2020 Dec 4.
10
The Proteasome Activators Blm10/PA200 Enhance the Proteasomal Degradation of N-Terminal Huntingtin.蛋白酶体激活剂 Blm10/PA200 增强了 N 端 Huntingtin 的蛋白酶体降解。
Biomolecules. 2020 Nov 20;10(11):1581. doi: 10.3390/biom10111581.